TNIK, actif, humain étiqueté GST, PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées Sf9, > = 70 % (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5305-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

TNIK or TRAF2 and NCK interacting kinase is characterized by an N-terminal kinase domain and a C-terminal GCK domain that serves a regulatory function. TN...


en savoir plus

Votre prix
$517.74 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

TNIK or TRAF2 and NCK interacting kinase is characterized by an N-terminal kinase domain and a C-terminal GCK domain that serves a regulatory function. TNIK is mainly expression in brain, heart, and spleen and it is a specific effector of RAP2 which regulate actin cytoskeleton. TNIK is autophosphorylated in a manner dependent upon lys54 in the ATP-binding pocket of its kinase domain and plays a main role in cytoskeleton regulation.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... TNIK(23043)
mol wt~67 kDa
NCBI accession no.NM_015028
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity54-82 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: